Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors. [electronic resource]
Producer: 20120320Description: 333-9 p. digitalISSN:- 1432-0843
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Area Under Curve
- Benzenesulfonates -- administration & dosage
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Drug Administration Schedule
- Drug Resistance, Neoplasm -- drug effects
- Gastrointestinal Diseases -- chemically induced
- Hematologic Diseases -- chemically induced
- Humans
- Metabolic Clearance Rate
- Middle Aged
- Neoplasms -- drug therapy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Pyridines -- administration & dosage
- Skin Diseases -- chemically induced
- Sorafenib
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.